MedCity News

BioPharma, Pharma

FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke

By Frank Vinluan

Artificial Intelligence

New Campaign Wants AI Applications To Look Beyond Speed

Healthcare has plenty of tedious administrative work which could benefit from AI's efficiency - but what if simply speeding up an already broken system isn't the answer? Healthcare leaders push for a re-built, AI-native system in Anterior's recent Beyond Faster Horses campaign.

By Jenna Congdon

MedCity Influencers

The Laboratory Industry’s Next Competitor May Be the Company on Your Patient’s Wrist

The industry’s next major competitor may never build another national laboratory network or employ thousands of phlebotomists. It may simply own the device that notices something first.

By David M. Jackson

Health Tech

Startup Supporting Caregivers Raises $3.5M in Seed Funding

Avanlee Care's seed round was led by BEA Venture Fund, with participation from existing investors, including Board Chair Esther Dyson, Chrysalis Ventures and FairBridge VC.

By Marissa Plescia

Latest Video

Latest News

BioPharma

Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health”

In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they are going beyond the pill in their GLP-1 strategy and responded to a question about whether they will exist two-to-three years from now.

By Arundhati Parmar

BioPharma, Pharma

Argenx Adds Oral Peptides to Its Immunology Strategy With $550M UNP Acquisition

Argenx’s Unnatural Products acquisition brings a macrocyclic peptides discovery platform for developing oral peptide drugs. The deal brings a new modality to Argenx, whose immunology R&D had focused on antibodies.

By Frank Vinluan

presented by

Sponsored Post, Artificial Intelligence

Automation Didn’t Dehumanize Care. Bad Systems Did.

We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

MedCity Influencers

Simulation-Guided Clinical Trials: Is EU Law Ready?

Simulations do not replace human judgment: they inform it, making transparent what would otherwise remain a “black box.” EU law does not require them today; but a proportionate embrace, in the right legislative vehicle, with clear methodological standards, and without crushing noncommercial research, could make trials safer, faster, cheaper, and more reliable, without sacrificing rigor.

By Marco Blei

BioPharma, Pharma

Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy

Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic sclerosis, during the American College of Rheumatology annual in Orlando this week. The biotech is part of a growing group of companies developing therapies that reset the immune system to treat autoimmune disease.

By Frank Vinluan

Consumer / Employer

What’s Driving the Consumerization of Healthcare?

Patients increasingly expect convenient, consumer-focused healthcare experiences, panelists said at the recent MedCity INVEST Digital Health Conference.

By Marissa Plescia

presented by

Sponsored Post

From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS

What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.

By Anna Keith, Vice President of LTSS Product & Strategy at Centene Corporation, and Phyllis Wojtusik, RN, Executive Vice President of Value-Based Care at Real Time Medical Systems

MedCity Influencers

Missing the Point: Isolation Alone Will Not Build AI Safety

Treating AI agents like contract nurses and minimizing their access to critical patient information certainly reduces potential risk. But, it also minimizes key opportunities.

By Gennady Gekht

BioPharma, Pharma

Bispecific J&J Drug Wins Speedy FDA Approval for Treating Head & Neck Cancer

Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The bispecific antibody was initially approved for treating certain lung cancers.

By Frank Vinluan

presented by

Sponsored Post

The Healthcare Payments Industry Faces a Perception Challenge

Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.

By Lisa Brooks, Vice President, Healthcare Partnerships

Hospitals, Payers

Experian Health Survey: Providers Struggle Amid Increasing Claim Denials

A new Experian Health survey finds that healthcare providers’ efforts to prevent claims denials are falling short, with many reporting an increase in denials over last year and increasingly complex payer requirements.

By Jenna Congdon

MedCity Influencers

The Big Challenge for AI in Healthcare Comes After Approval

Typically, software placed on the market will undergo changes and updates after its initial release. In the case of healthcare AI, changes can occur, often unexpectedly, even when the developers have not updated the model.

By Sara Jaworska

MedCity Influencers

Why Physician Leadership Is More Important Than Ever

One voice needs to be increasingly present in the rooms where healthcare’s future is being decided: the physician’s.

By Dr. Yogin Patel

MedCity Influencers

Myths of Customer Discovery

Customer discovery is a well accepted idea in any innovation process. At the core of it, it means talking to potential customers about an invention. In reality, it is a more evolved process, and often less understood than it first appears.

By Alok Gangaramany

Artificial Intelligence

Debunked Episode 31: CVS Health Restructure, AI ROI Report Findings, FTC Warning Letters

In the latest episode of the Debunked podcast, MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, talked about a new report by Bessemer Venture Partners assessing AI ROI, their insights on the CVS Health restructure, FTC warning letters sent to healthcare organizations, and more.

By Stephanie Baum

Payers, Consumer / Employer

How Can Payers Fit Into the Consumer Health Era?

During a panel at MedCity INVEST Digital Health, healthcare experts discussed the role of payers in the new consumer-driven healthcare era.

By Marissa Plescia

Physicians, Providers

Do We Have a Choice But to Ensure the Success of VBC? Part 1

In part 1, we delve into how physicians are looking at value-based care. It involves a visit to a local

By Arundhati Parmar

Devices & Diagnostics

Why the Wealth of Data From Wearables Are Important for Consumers and Clinicians

Growing use of wearable technologies and the data they produce was discussed by a panel at the MedCity News INVEST Digital Health Conference in Dallas.

By Frank Vinluan